Skip to main content

Pickering Grant's Form 4 filing

Vaxcyte, Inc. (PCVX) · filed Jun 18, 2026

Accession no.
0001258693-26-000010
Filed
Jun 18, 2026
Trade date
Jun 18, 2026
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.28M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pickering GrantCIK 0001258693Director, Officer (CHIEF EXECUTIVE OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 18, 2026Common StockMOption exerciseAcquired+225$1.79+$402.75497,164Direct
Jun 18, 2026Common StockSSaleDisposed−225$52.51−$11,814.75496,939Direct
Jun 18, 2026Common StockSSaleDisposed−22,236$52.50−$1,167,390474,703Direct
Jun 18, 2026Common StockSSaleDisposed−1,000$52.50−$52,500135,215Indirect
Jun 18, 2026Common StockSSaleDisposed−1,000$52.50−$52,500135,215Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 18, 2026Common StockMOption exerciseDisposed−225$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)